Cancer News

New colorectal cancer target found in stem cell gene

Researchers in Canada found that switching off a gene in the cancer stem cells that drive colon cancer stops them from being able to renew themselves. They say their study offers a starting point to treatments that could shut the cancer down.

Regulatory approval for biosimilar trastuzumab for treating breast cancer in India

A biotechnology company announced today that it has received Marketing Authorization from the Drugs Controller General of India (DCGI) for its biosimilar Trastuzumab being developed jointly with Mylan, for the treatment of Her 2 metastatic breast cancer.

Lung cancer is costliest cancer in European Union

The total cost of cancer care across the European Union (EU) was an estimated €126 billion (US$ 171.07 billion) in 2009, with lung cancer having the highest cost, at 15% of the total.

3D breast screen may cut recall rates

Advanced, digital breast tomosynthesis may reduce recall rates and increase cancer detection compared with digital mammography, researchers reported.

Test may help predict survival from ovarian cancer

By counting the number of cancer-fighting immune cells inside tumors, scientists say they may have found a way to predict survival from ovarian cancer.

Molecular imaging tracer aids in creation of treatment plans for brain metastases

Advanced imaging techniques can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Imaging results could also be used to predict progression-free survival.

Dense breasts riskier in younger women

The increased risk of cancer for women with denser breasts may be stronger in younger women, researchers reported.

FDA approves new drug for advanced prostate cancer

The U.S. Food and Drug Administration approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone.

Fewer mammograms mean more positive nodes?

The frequency of mammography may not have an impact on the size of tumors when they're discovered, but fewer screens may be associated with more lymph node positivity, researchers reported.

Researcher studies pediatric brain stem tumors

A new study entitled, "Comparative Multidimensional Molecular Analyses of Pediatric Diffuse Intrinsic Pontine Glioma Reveals Distinct Molecular Subtypes" found, for the first time, two distinct subtypes in pediatric diffuse intrinsic pontine gliomas (DIPG). It was published online in Acta Neuropathologica, a leading journal on pathology and pathogenesis of neurological disease.

Obesity, smoking might threaten implants after mastectomy

Obesity and smoking increase the risk of implant failure in women who undergo breast reconstruction soon after breast removal, according to a new study.

Two in three patients will be surviving by end of decade

The number of people dying from breast, prostate and bowel cancer will almost halve by 2020, new figures suggest.

Cigarette smoking after cancer diagnosis increases risk of death

Men who continued to smoke after a cancer diagnosis had an increased risk of death compared with those who quit smoking after diagnosis, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Protein in prostate tissue 'indicates increased cancer risk'

Researchers have discovered that men who have a specific protein present in prostate tissue biopsies may be at increased risk of developing prostate cancer. This is according to a study published in the Journal of Clinical Oncology.

Novartis bone marrow cancer drug meets goal in late-stage study

An experimental drug from Novartis to treat a type of bone marrow cancer met its primary goal in a late-stage study, the Swiss drugmaker said.

J&J, Pharmacyclics leukemia drug effective long term: study

A closely watched leukemia drug maintained its effectiveness in keeping the disease at bay for most patients, according to long-term follow-up data from a midstage study being presented at a major medical meeting.

AbbVie leukemia drug impresses in early-stage trial

An experimental drug for leukemia controlled or eliminated signs of the disease in more than 80% of patients who had failed to benefit from previous treatments. This is an unprecedented finding that could spur use of the medicine for other cancers.

Combo treatment: new standard for multiple myeloma?

A continuous, combined treatment of multiple myeloma outperformed standard care in older patients or those not eligible for stem cell transplant, according to a researcher at the annual meeting of the American Society of Hematology.

Boosting immune system to treat brain cancer

Brain cancer immune cells function may be compromised due to the disease. Researchers identified a drug that may re-activate them, and could lead to potential treatment.

Large differences in cancer survival between European countries still remain

Cancer survival still varies widely between European countries despite major improvements in cancer diagnosis and treatment during the first decade of the 21st century. This is according to the latest reports covering over 50% of the adult and 77% of the childhood population of Europe.

Insulin sensitizers reduce risk of cancer

A new study showed that a specific type of diabetes drug can decrease cancer risk by up to 32% in female patients with type 2 diabetes.

High response rates seen with oral Takeda myeloma drug: study

Most newly diagnosed multiple myeloma patients had a very strong response to an experimental oral drug, when given in combination with standard treatments, according to a trial.

Targeted therapy efficacy in metastatic Renal Cell Carcinoma (RCC) predicted by early tumor shrinkage

Metastatic renal cell carcinoma (mRCC) tumor shrinkage after targeted therapy may prolong long-term survival for this type of kidney cancer, research shows.

Targeted drugs may help in rare adrenal cancer

Adrenocortical carcinoma, a rare and dangerous endocrine malignancy with no effective drug treatments, may respond to targeted therapies, early studies suggest.

Targeted agent combinations in focus for breast cancer

Breast cancer treatment via targeted agent combinations (including Herceptin, Tykerb, Taxotere, Paraplatin, Avastin, Arimidex and Aromasin) will be in focus at an upcoming symposium.

CT screening overdiagnoses lung cancer

18% of lung cancers identified by low-dose Computed Tomography screening were slow-growing tumors that would not have affected patients during their lifetime.

Inflammation in prostate biopsies 'indicates reduced cancer risk'

Signs of inflammation in initial prostate biopsies may be related to reduced risk of prostate cancer diagnosis in future ones, according to new research on this controversial topic.

Keep on exercising, researchers advise older breast cancer survivors

One year of exercise can ensure steady maintenance of bone density to help prevent fractures. To build and maintain muscle strength, it is best for older breast cancer survivors to follow an ongoing exercise program of resistance and impact training.

Surviving ovarian cancer: scientists attack drug resistant cancer cells

Scientists have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates.

Caffeine and alcohol can change a part of DNA linked to aging and cancer

Researchers discovered that cancer and the aging process may be affected by coffee and alcohol, although dietary recommendations changes will depend on more research.

Login to your account

Did you forget your password?